Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Add to Basket
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN281752

Podocalyxin-Like (PODXL) antibody

Request
Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms Gp200, PC, PCLP, PCLP-1, Ly102, Pclp1, AW121214, podocalyxin, MEP21, Gp135, PCLP1, cPCLP1, Podxl, PODXL, podxl, fc18d02, wu:fc18d02
Reactivity
»Alternatives Human
Host
»Alternatives Mouse
Clonality (Clone) Monoclonal ()
Conjugate
»Alternatives Un-conjugated
Application
»Alternatives Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC)
Pubmed 4 references available
Catalog no. ABIN281752
Quantity 100 µg
Price
Contact our Customer Service for availability and price in your country.
Shipping to
Clone TRA-1-60
Isotype IgM
Specificity The TRA -1 -60 antibody recognizes a protein expressed on undifferentiated human embryonic stem cells (ES), embyronal carcinoma cells (EC), and embryonic germ cells (EG). Like other stem cell specific markers, the epitope recognized by the TRA -1 -60 antibody is lost upon cell differentiation. Contrary to early reports that the TRA -1 -60 epitope can be destroyed by neuraminidase digestion, new strudies have shown that TRA -1 -60 recognizes a neurominidase resistent antigen. The TRA -1 -60 antibody is known to specifically recognize a carbohydrate epitope on a keratan sulfated glycoprotein recently identified as podocalyxin, a member of the CD34 -related family of sialomucins. Podocalyxin is a transmembrane glycoprotein originally identified on epithelial glomerular cells known as podocytes, and the protein has also been implicated in the development of aggressiveness in a variety of cancers, including breast and prostate cancer., Human
Alternative Name TRA-1-60 (Podocalyxin)
Background The TRA160 antibody recognizes a protein expressed on undifferentiated human embryonic stem cells (ES), embyronal carcinoma cells (EC), and embryonic germ cells (EG). Like other stem cell specific markers, the epitope recognized by the TRA160 antibody is lost
Application Notes This TRA -1 -60 antibody has been tested by flow cytometric analysis of the human embryonal carcinoma (EC) line 2102Ep. This can be used at less than or equal to 0.5 µg per million cells in a 100 µl total staining volume. This antibody has also been tested by immunoblotting of 2102Ep cell extracts, yielding a band of approximately 200 -250 kDa (reducing and non -reducing conditions). It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. This TRA -1 -60 antibody has been reported for use in flow cytometric analysis, immunoprecipitation, immunoblotting, and immunofluorescence.
Restrictions For Research Use only
Buffer Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN3
Preservative Sodium azide
Storage 4 °C
Andrews, Banting, Damjanov et al.: "Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells." in: Hybridoma, Vol. 3, Issue 4, pp. 347-61, 1985 (PubMed).

Badcock, Pigott, Goepel et al.: "The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan." in: Cancer research, Vol. 59, Issue 18, pp. 4715-9, 1999 (PubMed).

Schopperle, DeWolf: "The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma." in: Stem cells (Dayton, Ohio), Vol. 25, Issue 3, pp. 723-30, 2007 (PubMed).

Chin, Fong, Goh et al.: "Identification of proteins from feeder conditioned medium that support human embryonic stem cells." in: Journal of biotechnology, Vol. 130, Issue 3, pp. 320-8, 2007 (PubMed).

Alternatives for antigen "Podocalyxin-Like (PODXL)", type "Antibodies"
Hosts (45), (40), (8), (6), (3)
Reactivities (85), (15), (6), (1)
Applications (77), (37), (21), (13), (11), (11), (11), (10), (5), (1), (1)
Conjugates (10), (7), (4), (4), (3), (2), (2)
Epitopes (13), (9), (7), (6), (5), (3), (3), (2), (1)
Beacon